KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Shares Issued (2016 - 2023)

Opko Health (OPK) has disclosed Shares Issued for 14 consecutive years, with -$545000.0 as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Shares Issued rose 62.72% year-over-year to -$545000.0, compared with a TTM value of -$1.3 million through Dec 2023, down 64.21%, and an annual FY2023 reading of -$272000.0, up 64.86% over the prior year.
  • Shares Issued was -$545000.0 for Q4 2023 at Opko Health, down from $273000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $76.1 million in Q4 2019 and bottomed at -$1.5 million in Q4 2022.
  • Average Shares Issued over 5 years is $5.5 million, with a median of $168500.0 recorded in 2021.
  • The sharpest move saw Shares Issued surged 131.03% in 2021, then plummeted 827.36% in 2022.
  • Year by year, Shares Issued stood at $76.1 million in 2019, then tumbled by 99.89% to $87000.0 in 2020, then soared by 131.03% to $201000.0 in 2021, then tumbled by 827.36% to -$1.5 million in 2022, then surged by 62.72% to -$545000.0 in 2023.
  • Business Quant data shows Shares Issued for OPK at -$545000.0 in Q4 2023, $273000.0 in Q3 2023, and -$1.5 million in Q4 2022.